Vital Signs - Pulmonary Drug Delivery: Going Beyond Lung Diseases

Vital Signs - Pulmonary Drug Delivery: Going Beyond Lung Diseases

 

RELEASE DATE
21-Jun-2010
REGION
North America
Research Code: 9561-00-A9-00-00
SKU: HC00598-NA-MR_04071
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00598-NA-MR_04071

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on June 21, 2010, provides a strategic analysis of trends in pulmonary drug delivery outside of respiratory diseases. Additionally, a company spotlight is provided for ZIOPHARM Oncology, a company focused on the research and development of small molecule therapies for the treatment of cancer. Reimbursement and regulatory news from the FDA is also provided for the week of May 31, 2010.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on June 21, 2010, provides a strategic analysis of trends in pulmonary drug delivery outside of respiratory diseases. Additionally, a company spotlight is provided for ZIOPHARM Oncology, a company focused on the research and development of small molecule therapies for the treatment of cancer. Reimbursement and regulatory news from the FDA is also provided for the week of May 31, 2010.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-A9-00-00
Is Prebook No